Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Using historical data can significantly enhance your ability to choose index funds. Learn how to leverage this information for better investments.
26,191 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Tech Mahindra's Mohit Joshi says AI will transform jobs, not vanish them. This piece surveys how IT services leaders ...
Palantir faces a pivotal moment as 2025 results reinforce growth in AI-related revenue, yet lofty valuations keep inv...
Amazon is betting big on hardware to power AI at scale. This article explains how amazon's chips driving growth in AI...
AMD jumps 8% mid-session as quarterly results highlight data-center momentum, prompting questions about whether it is...
A fresh wave of AI-driven momentum is reshaping Amazon's outlook, and investors are paying close attention. This arti...
A new payment option is pushing into the spotlight without fanfare. Pay-by-bank quietly gaining ground challenges the...
AMD’s stock has surged this year on AI demand, trading near $480 after a 129% year-to-date rally. A 129% year-to-date...
The shift in AI spending is reshaping winners and losers. This article explains why a power-semiconductor-focused com...
A warning from SK Hynix could ripple through the NAND market and Sandisk stock. This guide breaks down what the hynix...
Nebius shares fell about 13% in afternoon trading as the neocloud trade shows renewed pressure on asset-light AI clou...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...